RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 6.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $60 | -100.0% | 40,159 | -88.6% | 0.00% | -80.0% |
Q3 2022 | $417,000 | -66.7% | 353,244 | -15.6% | 0.01% | -68.8% |
Q1 2022 | $1,252,000 | +30.4% | 418,771 | +15.6% | 0.02% | +60.0% |
Q4 2021 | $960,000 | +954.9% | 362,271 | +1343.3% | 0.01% | +900.0% |
Q3 2021 | $91,000 | 0.0% | 25,100 | -5.2% | 0.00% | 0.0% |
Q1 2021 | $91,000 | -12.5% | 26,468 | -10.8% | 0.00% | 0.0% |
Q4 2020 | $104,000 | +8.3% | 29,680 | -25.6% | 0.00% | -50.0% |
Q3 2020 | $96,000 | +128.6% | 39,905 | +72.8% | 0.00% | +100.0% |
Q2 2020 | $42,000 | +75.0% | 23,099 | +107.7% | 0.00% | – |
Q4 2019 | $24,000 | -52.0% | 11,120 | -41.4% | 0.00% | -100.0% |
Q2 2019 | $50,000 | – | 18,980 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |